Foreign-Trade Zone (FTZ) 43-Battle Creek, Michigan; Authorization of Production Activity; Pfizer, Inc.; (mRNA COVID-19 Vaccine); Kalamazoo, Michigan
---
identifier: "/us/fr/2021-26682"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Foreign-Trade Zone (FTZ) 43-Battle Creek, Michigan; Authorization of Production Activity; Pfizer, Inc.; (mRNA COVID-19 Vaccine); Kalamazoo, Michigan"
title_number: 0
title_name: "Federal Register"
section_number: "2021-26682"
section_name: "Foreign-Trade Zone (FTZ) 43-Battle Creek, Michigan; Authorization of Production Activity; Pfizer, Inc.; (mRNA COVID-19 Vaccine); Kalamazoo, Michigan"
positive_law: false
currency: "2021-12-09"
last_updated: "2021-12-09"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Commerce Department"
document_number: "2021-26682"
document_type: "notice"
publication_date: "2021-12-09"
agencies:
- "Commerce Department"
- "Foreign-Trade Zones Board"
fr_citation: "86 FR 70110"
fr_volume: 86
docket_ids:
- "B-58-2021"
---
# Foreign-Trade Zone (FTZ) 43—Battle Creek, Michigan; Authorization of Production Activity; Pfizer, Inc.; (mRNA COVID-19 Vaccine); Kalamazoo, Michigan
On August 6, 2021, Pfizer, Inc. submitted a notification of proposed production activity to the FTZ Board for its facility within Subzone 43E, in Kalamazoo, Michigan.
The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including notice in the *Federal Register* inviting public comment (86 FR 46177, August 18, 2021). On December 6, 2021, the applicant was notified of the FTZ Board's decision that no further review of the activity is warranted at this time. The production activity described in the notification was authorized, subject to the FTZ Act and the FTZ Board's regulations, including Section 400.14.
Dated: December 6, 2021.
Elizabeth Whiteman,
Acting Executive Secretary.